Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Target Corporation (NYSE:TGT) right here. “I'm going to buy some Target at this price and then wait another five points and buy more,” he noted.

On Sept. 19, Target tapped PepsiCo, Inc‘s (NASDAQ:PEP) Jim Lee as its CFO and a member of its leadership team, which became effective Sept. 22. Lee brings over 25 years of experience in finance, strategy and more at PepsiCo. He takes over from COO Michael Fiddelke. Lee has served on multiple boards during his PepsiCo career, including Tropicana Brands Group and Celsius Holdings.

Check It Out:

• This billion-dollar fund has invested in the next big real estate boom, here's how you can join for $10.
  This is a paid advertisement. Carefully consider the investment objectives, risks, charges and expenses of the Fundrise Flagship Fund before investing. This and other information can be found in the Fund's prospectus. Read them carefully before investing.
• Your biggest returns may not come from the stock market. Invest the way colleges, pension funds, and the 1% do. Get started investing in commercial real estate today.

Cramer said to give him a call when Unity Software Inc. (NYSE:U) starts making a lot of money.

On Sept. 17, Macquarie analyst Tim Nollen maintained Unity Software with an Underperform rating and raised the price target from $12 to $15.

“I think at these levels you want to buy the stock of Merck (NYSE:MRK),” the “Mad Money” host said.

Trending: A billion-dollar investment strategy with minimums as low as $10 — you can become part of the next big real estate boom today.
This is a paid advertisement. Carefully consider the investment objectives, risks, charges and expenses of the Fundrise Flagship Fund before investing. This and other information can be found in the Fund's prospectus. Read them carefully before investing.

On Tuesday, Merck announced that the Phase 3 KEYNOTE-689 trial of Keytruda (pembrolizumab), as a perioperative treatment for patients newly diagnosed with stage III or IVA, resected, locally advanced head and neck squamous cell carcinoma met its primary endpoint of event-free survival (EFS).

When asked about Alumis Inc. (NASDAQ:ALMS), he said, “That is a really, incredibly speculative situation. As long as you know it's speculative, and you could lose everything on that one, go ahead. It's not my cup of tea.”

On Sept. 27, the company presented the 28-week open-label extension period data from its Phase 2 STRIDE trial of ESK-001.

SoundHound AI, Inc. (NASDAQ:SOUN) is a “meme stock, it loses money,” Cramer said.

On Sept. 30, DA Davidson analyst Gil Luria maintained SoundHound AI with a Buy and a $9.50 price target.

Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today. SmartAsset’s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

Keep Reading:

• Powell’s moves don’t have to doom your high yields. You can still make great returns in private credit. Find out how.
• With returns as high as 300%, it’s no wonder this asset is the investment choice of many billionaires. Uncover the secret.

This article Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock' originally appeared on Benzinga.com